SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-037078
Filing Date
2024-02-15
Accepted
2024-02-15 08:06:03
Documents
17
Period of Report
2024-02-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d754295d8k.htm   iXBRL 8-K 31767
2 EX-3.1 d754295dex31.htm EX-3.1 8982
3 EX-99.1 d754295dex991.htm EX-99.1 11963
7 GRAPHIC g754295page8.jpg GRAPHIC 8992
  Complete submission text file 0001193125-24-037078.txt   201463

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240214.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240214_lab.xml EX-101.LAB 18723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240214_pre.xml EX-101.PRE 11698
19 EXTRACTED XBRL INSTANCE DOCUMENT d754295d8k_htm.xml XML 3870
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24642187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)